Lafuwon Tablet 10 mg (Lafutidine)

Adult dosage

1. Short-term treatment of gastric ulcers: The usual dose is 10 mg of lafutidine orally twice daily, in the morning and before bedtime. In clinical trials in which treatment was administered for up to 8 weeks, most ulcers healed within 8 weeks, although healing time may occasionally vary by patient. 2. Short-term treatment of duodenal ulcers: The usual dose is 10 mg of lafutidine orally twice daily, in the morning and before bedtime. In clinical trials in which treatment was administered for up to 6 weeks, most ulcers healed within 6 weeks, although healing time may occasionally vary by patient. 3. Improvement of gastric mucosal lesions in acute and chronic gastritis: The usual dose is 10 mg of lafutidine orally once daily before bedtime. In clinical trials in which treatment was administered for up to 2 weeks, most lesions healed within 2 weeks, although healing time may occasionally vary by patient. 4. Combination antibiotic therapy in patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 days or 14 days. 5. Premedication before anesthesia: The usual dose is 10 mg of lafutidine per dose, administered orally twice (before bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer 10 mg of lafutidine per dose orally twice daily.

This medication should not be used in patients who are allergic to its ingredients. Additionally, since this drug contains lactose, patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, and glucose-galactose malabsorption should avoid taking it. Patients with a history of hypersensitivity to the drug or those with liver or kidney function issues, patients on dialysis, and elderly individuals should use this medication with caution. During the use of this drug, allergic reactions may lead to symptoms such as shock or anaphylaxis; if symptoms such as facial paleness, low blood pressure, generalized redness, or difficulty breathing occur, discontinue use immediately and consult medical personnel. Liver function impairment or jaundice may occur, so regular liver function tests should be conducted, and if abnormalities are found, the medication should be discontinued. There may be a decrease in the number of white blood cells or platelets; if symptoms such as sore throat, weakness, or fever appear, consult a doctor immediately. Additionally, serious side effects such as skin rashes, convulsions, and irregular heartbeats have been reported, so any unusual symptoms should be reported to medical personnel immediately. Common side effects reported in clinical trials include constipation, diarrhea, nausea, headache, drowsiness, dizziness, and facial flushing. If these symptoms persist or worsen, consult a professional. This drug may obscure symptoms of malignant tumors, so patients with gastric ulcers or suspected cases should undergo regular examinations to check for malignancy. Elderly patients may experience decreased bodily functions, so dosage and administration intervals should be adjusted, and the condition should be monitored carefully. Patients on dialysis may have increased plasma drug concentrations, so start at a low dose and administer carefully. Pregnant women or those who may become pregnant should take this medication only if deemed necessary by a doctor, and breastfeeding women should avoid it as it may be excreted in breast milk. Safety in pediatric patients has not been established, so use in children is not recommended. Finally, this medication should be stored out of reach of children and kept in its original container to prevent misuse or deterioration of quality.

• Shock
• symptoms of anaphylaxis
• facial pallor
• hypotension
• generalized rash
• dyspnea
• liver function impairment
• jaundice
• agranulocytosis
• pharyngitis

This drug may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is advisable to keep the storage temperature between 1 degree and 30 degrees Celsius at room temperature to ensure the drug's effectiveness.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle